Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37745

ACSF3 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

CRISPR/Cas9-edited polyclonal HEK293T cells with targeted ACSF3 disruption, designed for studying mitochondrial malonate metabolism. ACSF3 catalyzes malonate to malonyl-CoA for mtFAS and lipoic acid biosynthesis, regulating lipoylation of PDH, ??-KGDH, and GCSH. Factors such as PPARGC1A, MECR, and OXSM interact in this pathway. Knockout causes malonate and methylmalonate accumulation, modeling CMAMMA, and allows investigation of metabolic flux, mitochondrial respiration, and lipoic acid deficiency. Ideal for metabolomics, Seahorse assays, and complementation studies. For inquiries, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ACSF3

    Gene Identifier

    NCBI Gene ID 197322

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ACSF3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited heterogeneous population of human embryonic kidney 293T cells featuring a targeted disruption of the ACSF3 gene. This polyclonal knockout model enables loss-of-function studies without single-cell cloning, providing a robust tool for investigating mitochondrial malonate metabolism and related disorders.

Derived from the HEK293 lineage, HEK293T cells constitutively express the SV40 large T antigen, which enhances episomal replication of plasmids carrying the SV40 origin. Renowned for high transfectability and exceptional protein production, this host is ideal for studying mitochondrial enzyme function and producing viral vectors, making it a versatile platform for metabolic and genetic research.

ACSF3 encodes a mitochondrial matrix malonyl-CoA synthetase that catalyzes the conversion of malonate to malonyl-CoA, an essential substrate for mitochondrial fatty acid synthesis (mtFAS) and subsequent lipoic acid production. ACSF3 expression is regulated by mitochondrial biogenesis regulators PPARGC1A, TFAM, and NRF1, and its activity depends on malonate availability. The malonyl-CoA product feeds into the mtFAS pathway, where it interacts with MECR, OXSM, and ACPM to generate octanoyl-ACP, the precursor for lipoic acid. Lipoic acid serves as a cofactor for lipoylation of key metabolic enzymes, including PDH, ??-KGDH, and GCSH, placing ACSF3 upstream of critical cellular redox and energy processes.

In HEK293T cells, ACSF3 disruption halts mtFAS, causing malonate and methylmalonate accumulation and impairing lipoylation of PDH, ??-KGDH, and GCSH, thereby modeling combined malonic and methylmalonic aciduria (CMAMMA). This polyclonal knockout population allows investigation of mitochondrial dysfunction without clonal bias, making it suitable for studies of metabolic reprogramming and oxidative stress. The HEK293T background??s mitochondrial reliance under defined conditions further highlights the impact of lipoic acid deficiency on TCA cycle flux and cellular respiration.

Research applications include metabolomics profiling of malonate, methylmalonate, and lipoic acid; Seahorse respiration analysis; immunofluorescence for mitochondrial morphology; and knockout confirmation by Sanger sequencing or T7E1 assay. These cells are also valuable for complementation experiments and therapeutic screening. For further details or support, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)